Instrumentation Laboratory HemosIL AcuStar ADAMTS13 Activity - HSA Registration DE0506449
Access comprehensive regulatory information for Instrumentation Laboratory HemosIL AcuStar ADAMTS13 Activity in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0506449 and owned by Instrumentation Laboratory Company. The device was registered on December 06, 2021.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The HemosIL AcuStar ADAMTS13 Activity is a quantitative, fully automated, chemiluminescent immunoassay (CIA) for the measurement of ADAMTS13 Activity. The assay is for use in human 3.2% or 3.8% citrated plasma on the ACL AcuStar® in a laboratory setting by healthcare professionals. The assay results aid in the diagnosis and monitoring of Thrombotic Thrombocytopenic Purpura (TTP). The results should be used in conjunction with other clinical and laboratory findings. For use in adult population. For prescription use only